M
Maryann Mazer-Amirshahi
Researcher at MedStar Washington Hospital Center
Publications - 116
Citations - 1394
Maryann Mazer-Amirshahi is an academic researcher from MedStar Washington Hospital Center. The author has contributed to research in topics: Emergency department & Medicine. The author has an hindex of 15, co-authored 94 publications receiving 1000 citations. Previous affiliations of Maryann Mazer-Amirshahi include Georgetown University & Children's National Medical Center.
Papers
More filters
Journal ArticleDOI
Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010.
Maryann Mazer-Amirshahi,Maryann Mazer-Amirshahi,Peter M. Mullins,Irit R. Rasooly,John N. van den Anker,Jesse M. Pines +5 more
TL;DR: There has been a dramatic increase in prescribing of opioid analgesics in U.S. EDs in the past decade, coupled with a modest increase in pain-related complaints as mentioned in this paper.
Journal ArticleDOI
Pharmacotherapy in COVID-19; A narrative review for emergency providers.
TL;DR: The effectiveness of current therapy options for COVID-19 is summarized and the controversial use of non-steroidal anti-inflammatory drugs (NSAIDs), angiotensin converting enzyme (ACE) inhibitors, and angiotENSin receptor blockers (ARBs) is addressed.
Journal ArticleDOI
Vitamin C: The Next Step in Sepsis Management?
TL;DR: The physiologic role of vitamin C as an antioxidant, in vasopressor synthesis, in immune function, and review detail recent studies in sepsis are discussed.
Journal ArticleDOI
Alcohol-Related Visits to US Emergency Departments, 2001-2011.
TL;DR: Alcohol-related ED visits are increasing at a greater rate than overall ED visits and represent a growing burden on hospital resources.
Journal ArticleDOI
Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice
Farha Quadri,Maryann Mazer-Amirshahi,Erin R. Fox,Kristy L. Hawley,Jesse M. Pines,Mark S. Zocchi,Larissa S May +6 more
TL;DR: There were a substantial number of drug shortages from 2001 to 2013, with a dramatic rise in shortages since 2007, and shortages of agents used to treat multidrug-resistant infections are of concern due to continued transmission and limited treatment options.